UCB
A Device Documentation Lead supports the development and lifecycle of drug–device combination products, ensuring robust, compliant documentation for regulatory submissions and design reviews.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Director, Device Development
AstraZeneca
GRA Device Lead (Associate Director) - Digital Health
Sanofi
Principal Scientist – Device Technical and Engineering Lead (Director Equivalent)
Merck & Co., Inc.
Senior Director and Regulatory Platform Lead GRA CMC, Device and Drug-Device Combinations Human Factors
BioLife Plasma Services
Global Regulatory Affairs Device Lead (Associate Director)
Sanofi
Director, CMC Regulatory Affairs – Combination Products and Device
Gilead Sciences